- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20:10 | Pharma makes Cannes Lions comeback with 'brilliant basics' | ||
| 18:10 | Bavarian Nordic sells FDA priority review voucher from chikungunya vaccine approval for $160M | ||
| 18:10 | Trump administration considers measures to limit DTC drug advertising: Bloomberg | ||
| 17:10 | BioNTech to wind down cell therapy manufacturing in Maryland, lay off 63 as it ends development of CAR-T drug in testicular cancer | ||
| Di | Lawmakers refresh tax-dodging accusations against Big Pharma, targeting Pfizer, AbbVie and others | ||
| Di | Ousted ACIP members fire back at RFK Jr.'s 'destabilizing' decisions for US vaccine policy | ||
| Di | IPG Health outfits dominate another Cannes agency showdown, with Real Chemistry and Ogilvy Health earning accolades, too | ||
| Di | Pharma roars onto the Cannes Pharma Lions podium, with Viatris winning Grand Prix and Biogen taking home Gold | ||
| Di | With FDA nod for HAE drug Andembry, CSL set to compete with Takeda's Takhzyro | ||
| Di | In setback for biopharma, Senate version of Trump's tax bill drops Orphan Cures Act | ||
| Di | Trump rekindles pharmaceutical tariff threat, suggesting import duties could come 'very soon': Reuters | ||
| Di | Shrinking budgets and rising targets pile pressure on pharma marketers: survey | ||
| Di | Senators bring back bill to bolster US pharma supply chain by awarding contracts to domestic producers | ||
| Mo | Roche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short | ||
| Mo | Veranova, Enzene plot new biologic manufacturing expansions on East Coast | ||
| Mo | Precision medicine's next frontier: unlocking the power of biospecimens | ||
| Mo | Supernus acquires struggling Sage for $561M, taking a flier on postpartum depression drug Zurzuvae | ||
| Mo | Eli Lilly adds high-dose Zepbound options to lineup of cheaper vials available on self-pay website | ||
| Mo | Sarepta reports 2nd death after DMD gene therapy Elevidys, stops dosing in half of patients | ||
| Mo | AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication | ||
| Mo | FDA's 'heavy workload' blamed for delays to KalVista's angioedema drug approval decision | ||
| Mo | Biogen leads Cannes Lions Pharma shortlist, with BMS, Novartis cracking Health & Wellness category | ||
| Fr | Sens. Sanders, King propose legislation to ban direct-to-consumer ads for prescription drugs | ||
| Fr | Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation | ||
| Fr | Fierce Pharma Asia-Pfizer CEO talks bispecific deal; Otsuka's kidney disease win; Novartis-MSN Entresto feud |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .